Gorlin syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Condition:   Gorlin Syndrome Interventions:   Drug: Patidegib Topical Gel;   Drug: Vehicle Gel Sponsors:   Sol-Gel Technologies, Ltd.;   Premier Research Group plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Conditions: Gorlin Syndrome Interventions: Drug: Patidegib Topical Gel; Drug: Vehicle Gel Sponsors: Sol-Gel Technologies, Ltd.; Premier Research Group plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Nevoid Basal Cell Carcinomas in Gorlin Syndrome
Conditions:   Basal Cell Carcinoma;   Gorlin Syndrome Intervention:   Other: Active surveillance Sponsor:   Oslo University Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials